Chuenkitmongkol, SunateSunateChuenkitmongkolSolante, RontgeneRontgeneSolanteBurhan, ErlinaErlinaBurhanChariyalertsak, SuwatSuwatChariyalertsakChiu, Nan-ChangNan-ChangChiuDo-Van, DungDungDo-VanHusin, MasliyanaMasliyanaHusinHwang, Kao-PinKao-PinHwangKiertiburanakul, SasisopinSasisopinKiertiburanakulKulkarni, Prasad SPrasad SKulkarniPING-ING LEELobo, Rommel CrisenioRommel CrisenioLoboNghia, Cao HuuCao HuuNghiaOng-Lim, AnnaAnnaOng-LimSivasampu, SheaminiSheaminiSivasampuSuah, Jing LianJing LianSuahTok, Peter Seah KengPeter Seah KengTokThwaites, GuyGuyThwaites2023-01-182023-01-182022-091476-0584https://scholars.lib.ntu.edu.tw/handle/123456789/627428COVID-19 vaccines have been highly effective in reducing morbidity and mortality during the pandemic. While primary series vaccination rates are generally high in Southeast Asian (SEA) countries, various factors have limited the rollout and impact of booster doses.enAZD1222; COVID-19; Omicron; Southeast Asia; mRNA; real-world; vaccine effectiveness; variants of concern; vector; waning immunity[SDGs]SDG3review10.1080/14760584.2022.2092472357484942-s2.0-85133777621WOS:000819761400001https://api.elsevier.com/content/abstract/scopus_id/85133777621